Brief: Theranexus Announces New Ipo Value At 20.4 Million Euros
Nov 27 (Reuters) - THERANEXUS SA ALTHX.PA :
* IPO VALUE IS NOW EUR 20.4 MLN
* SAYS PORTZAMPARC PARTIALLY EXERCISED OVER-ALLOTMENT OPTION
GIVING RISE TO ISSUANCE OF 53,753 ADDITIONAL NEW SHARES
* ISSUE AT OFFER PRICE OF 15.50 PER SHARE, FOR AN AMOUNT
OF
833,171.50
Source text for Eikon: urn:newsml:reuters.com:*:nACT51128
Further company coverage: ALTHX.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease